The pathogenesis of hepatitis C virus is influenced by cytomegalovirus (Q43040318)

12 November 2017

The pathogenesis of hepatitis C virus is influenced by cytomegalovirus (English)

1 reference

12 November 2017

1 reference

1 reference

Raymund R Razonable

1

1 reference

12 November 2017

Kelly W Burak

2

1 reference

12 November 2017

Hester van Cruijsen

3

1 reference

12 November 2017

Robert A Brown

4

1 reference

12 November 2017

Michael R Charlton

5

1 reference

12 November 2017

Thomas F Smith

6

1 reference

12 November 2017

Mark J Espy

7

1 reference

12 November 2017

Walter Kremers

8

1 reference

12 November 2017

Jennie A Wilson

9

1 reference

12 November 2017

Cynthia Groettum

10

1 reference

12 November 2017

Russell Wiesner

11

1 reference

12 November 2017

Carlos V Paya

12

1 reference

12 November 2017

language of work or name

English

0 references

publication date

26 September 2002

1 reference

Clinical Infectious Diseases

12 November 2017

1 reference

12 November 2017

35

1 reference

12 November 2017

8

1 reference

12 November 2017

974-981

1 reference

Hepatitis C virus infection

12 November 2017

1 reference

Graft loss following liver transplantation in patients with chronic hepatitis C.

21 January 2018

1 reference

Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury

21 January 2018

1 reference

Hepatitis C infection in patients undergoing liver retransplantation

21 January 2018

1 reference

Predictors of patient and graft survival following liver transplantation for hepatitis C.

21 January 2018

1 reference

Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation

21 January 2018

1 reference

Long-term outcome of hepatitis C infection after liver transplantation

21 January 2018

1 reference

The indirect effects of cytomegalovirus infection on the outcome of organ transplantation

21 January 2018

1 reference

The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.

21 January 2018

1 reference

Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation.

21 January 2018

1 reference

Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C.

21 January 2018

1 reference

Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.

21 January 2018

1 reference

Human beta-herpesvirus interactions in solid organ transplant recipients

21 January 2018

1 reference

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

Definitions of cytomegalovirus infection and disease in transplant recipients

21 January 2018

1 reference

Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems

21 January 2018

1 reference

Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts

21 January 2018

1 reference

Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation

21 January 2018

1 reference

A model to predict survival in patients with end-stage liver disease

21 January 2018

1 reference

Prognostic Value of Child-Turcotte Criteria in Medically Treated Cirrhosis

21 January 2018

1 reference

Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation

21 January 2018

1 reference

A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation

21 January 2018

1 reference

High incidence of active cytomegalovirus infection among septic patients

21 January 2018

1 reference

Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial.

21 January 2018

1 reference

Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir

21 January 2018

1 reference

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

21 January 2018

1 reference

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

21 January 2018

1 reference

Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study.

21 January 2018

1 reference

The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease

21 January 2018

1 reference

Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs

21 January 2018

1 reference

THE INFLUENCE OF CYTOMEGALOVIRUS VIRAEMIA ON THE OUTCOME OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION12

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/342911

1 reference

12 November 2017

1 reference